Cargando…

Neoadjuvant Treatments for Pancreatic Ductal Adenocarcinoma: Where We Are and Where We Are Going

Background: Pancreatic ductal adenocarcinoma (PDAC) represents a challenging disease for the surgeon, oncologist, and radiation oncologist in both diagnostic and therapeutic settings. Surgery is currently the gold standard treatment, but the role of neoadjuvant treatment (NAD) is constantly evolving...

Descripción completa

Detalles Bibliográficos
Autores principales:	Coppola, Alessandro, Farolfi, Tommaso, La Vaccara, Vincenzo, Iannone, Immacolata, Giovinazzo, Francesco, Panettieri, Elena, Tarallo, Mariarita, Cammarata, Roberto, Coppola, Roberto, Caputo, Damiano
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10253643/ https://www.ncbi.nlm.nih.gov/pubmed/37297872 http://dx.doi.org/10.3390/jcm12113677

Ejemplares similares

New Frontiers of Early Diagnosis of Pancreatic Fistula after Pancreaticoduodenectomy
por: Coppola, Alessandro, et al.
Publicado: (2022)

Role of Neoplastic Markers in Pancreatic Adenocarcinoma
por: Coppola, Alessandro, et al.
Publicado: (2022)

Right hepatic artery anomalies in pancreatoduodenectomy—a risk for arterial resection but not for postoperative outcomes
por: La Vaccara, Vincenzo, et al.
Publicado: (2023)

Role of CA 19.9 in the Management of Resectable Pancreatic Cancer: State of the Art and Future Perspectives
por: Coppola, Alessandro, et al.
Publicado: (2022)

Neoadjuvant Therapy for Pancreatic Ductal Adenocarcinoma: Where Do We Go?
por: Wang, Chenqi, et al.
Publicado: (2022)

CA19.9 Serum Level Predicts Lymph-Nodes Status in Resectable Pancreatic Ductal Adenocarcinoma: A Retrospective Single-Center Analysis
por: Coppola, Alessandro, et al.
Publicado: (2021)

Postoperative procalcitonin is a biomarker for excluding the onset of clinically relevant pancreatic fistula after pancreaticoduodenectomy
por: Coppola, Alessandro, et al.
Publicado: (2023)

Alzheimer’s disease and infections, where we stand and where we go
por: Monastero, Roberto, et al.
Publicado: (2014)

The peritumoral brain zone in glioblastoma: where we are and where we are going
por: Giambra, Martina, et al.
Publicado: (2022)

The Clusmy Child: Where Are We and Where Are We Going?
por: Hadders-Algra, Mijna, et al.
Publicado: (2003)

European HEPnet: where we are and where we are going
por: Carpenter, B E, et al.
Publicado: (1990)

Iron health: where are we and where are we going?
por: Gotardo, Glória Ines Beal
Publicado: (2011)

Hip Arthroscopy: Where We Are, and Where We Are Going
por: Park, Myung Sik, et al.
Publicado: (2015)

Bioactive Glasses: Where Are We and Where Are We Going?
por: Baino, Francesco, et al.
Publicado: (2018)

Diabetic cardiomyopathy: where we are and where we are going
por: Lee, Wang-Soo, et al.
Publicado: (2017)

Obstetric ultrasound: where are we and where are we going?
por: Abramowicz, Jacques S
Publicado: (2021)

Hidradenitis Suppurativa: Where We Are and Where We Are Going
por: Scala, Emanuele, et al.
Publicado: (2021)

Where We Are and Where We Are Going in Nut Research
por: Salas-Salvadó, Jordi, et al.
Publicado: (2023)

COVID-19: Where We Are and Where We Are Going
por: Abenavoli, Ludovico, et al.
Publicado: (2023)

Telemedicine in ophthalmology - where are we and where are we going?
por: Pîrvulescu, Ruxandra
Publicado: (2023)

Neoadjuvant treatments in triple-negative breast cancer patients: where we are now and where we are going
por: Omarini, Claudia, et al.
Publicado: (2018)

Where are we coming from? What are we? Where are we going?
por: Ellis, John R.
Publicado: (1995)

The living universe: where are we? who are we? where are we going?
por: Elgin, Duane, et al.
Publicado: (2009)

Where are we going?
por: Pawl, Ronald P.
Publicado: (2010)

Vesicoureteral Reflux: Where Have We Been, Where Are We Now, and Where Are We Going?
por: McLorie, Gordon A.
Publicado: (2008)

TSACO’s Third Anniversary: where we were, where we are, and where we’re going
por: Fabian, Timothy
Publicado: (2019)

Anticipation in Lynch Syndrome: Where We Are Where We Go
por: Bozzao, Cristina, et al.
Publicado: (2011)

Free software at CERN: where are we, where are we going?
por: Fluckiger, Francois, et al.
Publicado: (2013)

Molecular targeted agents—where we are and where we are going
por: Yan, Li
Publicado: (2013)

Dermatology: Where are We Coming from and Where are We Going to?
por: van de Kerkhof, Peter C. M.
Publicado: (2014)

CUREs in biochemistry—where we are and where we should go
por: Bell, Jessica K., et al.
Publicado: (2016)

Colon Capsule Endoscopy: Where Are We and Where Are We Going
por: Han, Yoo Min, et al.
Publicado: (2016)

Chronic Pulmonary Aspergillosis—Where Are We? and Where Are We Going?
por: Hayes, Gemma E., et al.
Publicado: (2016)

Accommodative intraocular lenses: where are we and where we are going
por: Alió, Jorge L., et al.
Publicado: (2017)

Research in Vascular Medicine: Where We Are and Where We Are Going
por: Qanadli, Salah D.
Publicado: (2020)

Single-use duodenoscopes: where are we and where are we going?
por: Peter, Shajan, et al.
Publicado: (2021)

Pediatric Sepsis Research: Where Are We and Where Are We Going?
por: Massaud-Ribeiro, Letícia, et al.
Publicado: (2022)

Nuclear‐medicine probes: Where we are and where we are going
por: Gonzalez‐Montoro, Andrea, et al.
Publicado: (2022)

Mathematics anxiety—where are we and where shall we go?
por: Cipora, Krzysztof, et al.
Publicado: (2022)

AI in medicine: Where are we now and where are we going?
por: Shandhi, Md Mobashir Hasan, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_dst89kp5qvcihkt2ss0m25nsuq